about
Coming of age: the artificial pancreas for type 1 diabetesClosed-loop insulin delivery for treatment of type 1 diabetesClinical review: Consensus recommendations on measurement of blood glucose and reporting glycemic control in critically ill adultsOvernight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studiesOutcome Measures for Artificial Pancreas Clinical Trials: A Consensus ReportDay and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-managementSimulation environment to evaluate closed-loop insulin delivery systems in type 1 diabetes.Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial.Continuous glucose control in the ICU: report of a 2013 round table meeting.Glucose control in intensive care: usability, efficacy and safety of Space GlucoseControl in two medical European intensive care unitsAssessing the effectiveness of 3 months day and night home closed-loop insulin delivery in adults with suboptimally controlled type 1 diabetes: a randomised crossover study protocol.Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover studySafety of closed-loop therapy during reduction or omission of meal boluses in adolescents with type 1 diabetes: a randomized clinical trialClosed-loop insulin delivery during pregnancy complicated by type 1 diabetes.Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial.Pharmacokinetics of diluted (U20) insulin aspart compared with standard (U100) in children aged 3-6 years with type 1 diabetes during closed-loop insulin delivery: a randomised clinical trialModelling endogenous insulin concentration in type 2 diabetes during closed-loop insulin delivery.A stepwise approach toward closed-loop blood glucose control for intensive care unit patients: results from a feasibility study in type 1 diabetic subjects using vascular microdialysis with infrared spectrometry and a model predictive control algoriFitting dynamic models with forcing functions: application to continuous glucose monitoring in insulin therapy.Safety and efficacy of 24-h closed-loop insulin delivery in well-controlled pregnant women with type 1 diabetes: a randomized crossover case series.Rapid model exploration for complex hierarchical data: application to pharmacokinetics of insulin aspart.Evaluating the Performance of a Novel Embedded Closed-loop System.Meta-analysis of overnight closed-loop randomized studies in children and adults with type 1 diabetes: the Cambridge cohortArtificial Pancreas Project at Cambridge 2013Unsupervised home use of an overnight closed-loop system over 3-4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes.Closed-loop insulin delivery in type 1 diabetes.Validity of triple- and dual-tracer techniques to estimate glucose appearance.Measurement delay associated with the Guardian RT continuous glucose monitoring system.Closed-loop for type 1 diabetes - an introduction and appraisal for the generalist.Accuracy of Continuous Glucose Monitoring During Three Closed-Loop Home Studies Under Free-Living Conditions.Home Use of an Artificial Beta Cell in Type 1 DiabetesAssessing performance of closed-loop insulin delivery systems by continuous glucose monitoring: drawbacks and way forward.Evaluating the accuracy and large inaccuracy of two continuous glucose monitoring systems.Accuracy of continuous glucose monitoring during exercise in type 1 diabetes pregnancy.Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial.Physical activity energy expenditure and glucose control in pregnant women with type 1 diabetes: is 30 minutes of daily exercise enough?Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trialInsulin administration and rate of glucose appearance in people with type 1 diabetesDay-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial.Effects of prolonged fasting and sustained lipolysis on insulin secretion and insulin sensitivity in normal subjects.
P50
Q26745886-D31A5126-6D38-4714-A2A0-C9D5807F88CEQ27008127-3F017CA1-0757-4EC6-9ABD-87EBC8584860Q27021638-C4644EFF-5FCB-4062-B219-273C38A358C4Q28741005-03A6A2F8-CDB2-4418-9CE0-4A2D8120EC53Q30276532-F3B01FFD-4388-4920-8B8D-0FA523A5A839Q30409243-3994A7DF-892D-4450-B3EC-68ECACD6DDCCQ30433675-621CBF41-1C90-47E9-8DEA-DED9925DEC40Q33750788-4E50F17D-B988-4657-82DD-9A2F803AF414Q33833330-B9D6C484-AF2F-4071-B258-42A7FCB2EA96Q33987913-1476F155-0EA6-4CEF-BDF5-D7703FC28F80Q34151693-6FE553F3-7CCE-43D4-9162-2A53BDB545DEQ34194737-E6EF2FD4-C743-4843-AF1B-53D7323625C4Q34315968-251CC3AB-8A1D-4B77-969C-6C891FB417E1Q34507197-FBB3C87F-EA5D-4C6A-A97F-F4829AFDDCF3Q34616506-78D93A5D-A111-44FC-B971-D951C8C98021Q35153007-8049CCB1-DAA4-4B20-BD6D-E9C8263FB38CQ35176744-5921D652-4680-4AC0-9182-845E561D3A67Q35336990-02407948-0D24-4A58-9C00-329F65923935Q35447304-B1857CFD-CB9F-4613-AEE8-FDB020010FC5Q35563688-52B325C0-7598-4F32-BC31-986B8FEB1E7AQ35642529-7A805BCB-C5B3-4FC9-A127-8C1F03711D35Q35682761-4B8A322A-1490-4104-A132-3CDFCB560F2AQ35684916-3D9ECB97-7493-49D3-AD06-8879E6AE8B6EQ35858586-3A08387A-2914-4DC1-9E24-E3AD747C1B89Q35877744-318B24C7-40A5-444B-B0E5-2006B8E72CDBQ35954124-04AA8170-4B7A-4A2B-A828-A1BAA9737A8FQ36042126-EE53071D-8A9D-4D3F-B1C7-20A8BC3584D4Q36189939-83D109CF-D135-4494-9F7A-E962EC9620D7Q36258001-0FA1F68C-EF8F-4986-A528-D71B1A62BB3FQ36291620-6D76424B-2CB0-42CF-A599-41EAF336BD3DQ36419734-29DE1293-229F-457F-8870-B9D1121168DBQ36520578-AB30AD99-9D87-4017-8F84-10260B114C97Q36572849-5A0805ED-4375-4AA5-B7A4-D7B55727C14AQ36687094-A7CA3B3D-8F97-485F-8EDA-384540006256Q36720273-256574C7-AE0C-46BB-8A6C-3EC7C47927E7Q36782639-2F4B9CDF-0232-4F72-AC8D-9D3CBB69C795Q36800053-A47E610B-728E-4C57-9CE2-41CF1A161083Q36945315-7D7DF9AD-ED6B-4D47-962F-23ACC53BC0E9Q37025568-704E8871-792E-4EC7-893D-CC5D8341EF95Q37138709-C85C3688-9842-473B-AE84-2F7B37E814D7
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Roman Hovorka
@ast
Roman Hovorka
@en
Roman Hovorka
@es
Roman Hovorka
@nl
Roman Hovorka
@sl
type
label
Roman Hovorka
@ast
Roman Hovorka
@en
Roman Hovorka
@es
Roman Hovorka
@nl
Roman Hovorka
@sl
prefLabel
Roman Hovorka
@ast
Roman Hovorka
@en
Roman Hovorka
@es
Roman Hovorka
@nl
Roman Hovorka
@sl
P1053
J-4123-2016
P106
P1153
55145131500
P21
P2456
P31
P3829
P3835
roman-hovorka
P496
0000-0003-2901-461X